Omeprazole Sulfide CAS 73590-85-9 Puritas >99.0% (HPLC) Factory

Description:

Chemical Name: Omeprazole Sulfide

Synonyma: Ufiprazole

CAS: 73590-85-9

Puritas: >99.0% (HPLC)

Aspectus: Alba ad Off-White vel Crystal

High Quality, Commercial Production

Medium Omeprazole / Esomeprazole

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Omeprazole intermedia Cum Puritate
Omeprazole CAS 73590-58-6
Omeprazole Hydroxy Compone CAS 86604-78-6
Omeprazole Chloride Compone CAS 86604-75-3
Omeprazole Sulfide CAS 73590-85-9
2-Mercapto-5-Methoxybenzimidazole CAS 37052-78-1
2-Cyano-3-Methylpyridine CAS 20970-75-6
2,3,5-Trimethylpyridine CAS 695-98-7

Chemical Properties:

Nomen chemicum	Omeprazole Sulfide
Synonyma	Ufiprazole;Omeprazole Sulfur Ether;Esomeprazol EP Impurity C;Omeprazole EP Impurity C;5-Methoxy-2-[[(4-Methoxy-3,5-Dimethyl-2-pyridyl)methyl]thio]benzimidazole;5-Methoxy-2-{[(4-Methoxy-3,5-Dimethyl-2-Pyridinyl)methyl]thio}-1H-Benzimidazole
CAS Number	73590-85-9
CATTUS Number	RF-PI1914
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C17H19N3O2S
M. Pondus	329.42
Liquescens punctum	122.0 ad 126.0℃
Solubilitas	Solutum in Methanol
Density	1.28±0.10 g/cm3
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White vel Crystal
Puritas / Analysis Methodus	>99.0% (HPLC)
Damnum in Siccatio	<1.00%
Residere in Ignition	<0.20%
Metalla gravia (ut Pb)	<20ppm
una immunditia	<0.50%
Totalis immunditias	<1.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Medium Omeprazole / Esomeprazole

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

Omeprazole Sulfide (CAS: 73590-85-9) est medius usus in productione sentinae gastrici inhibitores, Omeprazole (CAS: 73590-58-6) et Esomeprazole (CAS: 119141-88-7), Esomeprazole Sodium. CAS: 16179-78-7).Inhibitorem cytochromi P450 2C19 directum actorem esse relatum est in microsomes iecur humanum fundens (IC50 = 9.7 μM).Omeprazole Sulfide metabolite Omeprazole est.Natrium esomeprazole est forma salis sodium esomeprazole.Communiter usus est medicamento anti-ulceris, quod primum feliciter elaboratum est a societate Suecica Astra Zeneca primum.Pertinet ad sentinam proton inhibitoris.Inhibitoris sentinae protoniensis electio primaria est ad ulcerem pepticum, refluxum gastro-oesophagi et alios morbos acidi relatos.In statu vulgo amet uso PPI quinque species sunt: Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole et Esomeprazole.Ut primum PPI, efficacia medicamentorum omeprazolis in curandis morbis acidis actis divulgatis est.Esomeprazole est S-isomer de Omeprazole, quod secretionem gastrici acidum minuere potest per mechanismum specificum.Inhibitor specificus est pro inhibitoris sentinae protonensis in cellula parietali.Propter metabolicae commoditatem esomeprazolam, maiorem bioavailbilitatem et pharmacokineticam constantiorem habet quam partem suam, Omeprazole Sodium, medicamentum augens quod sentinam protonom attingit.Partes eius acidi gastrici temperantiae multo meliores sunt quam aliae soleatus inhibitores protónum, ut Lansoprazole, Pantoprazole, et Rabeprazole.